Grifols, a global healthcare company and leading manufacturer of plasma-derived medicines, has announced a collaboration with ...

Spanish plasma-derived medicines specialist Grifols revealed it is collaborating with Dutch biotechnology start-up, FcR ...

A phase 3 trial evaluating sotatercept-csrk (Winrevair™) in adults with pulmonary arterial hypertension (PAH; World Health Organization Group 1) ...

SARS-CoV-2 binds to the human cell receptor angiotensin-converting enzyme 2 ... Inc. Tainan, Taiwan. C-terminal Fc-tagged human ACE2 recombinant protein (ACE2-hFc) was purified from CHO cells (Cat. No ...

Within the G protein-coupled receptor (GPCR ... A single cell suspension was prepared followed by blockade of Fc receptors with a blocking antibody (2.4G2 BD Biosciences, UK). In the presence of the ...

January 2025 kicked off with a wave of impactful biotech deals, setting the stage for an exciting year of innovation.

These findings are of important clinical relevance, as the therapeutic potential of transmembrane activator and cyclophilin ligand interactor-Fc (atacicept ... The cDNA encoding soluble extracellular ...

The table below is a review of notable updates that occurred in January 2025 for investigational products in development.

The table below is a review of notable updates that occurred in January 2025 for investigational products in development (not an inclusive list). Click on the status to view our full coverage.